INTERNATIONAL PATENT: GNT PHARMA CO., LTD., 주식회사 지엔티파마 FILES APPLICATION FOR "COMPOSITION AND METHOD FOR REDUCING BRAIN DAMAGE, DISABILITY AND/OR DEATH BY COMBINED THERAPY WITH TETRAFLUOROBENZYL DERIVATIVE AND HYPOTHERMIA"

GENEVA, July 14 -- GNT PHARMA CO., LTD. (23, Yonggu-daero 1855beon-gil, Giheung-gu,Yongin-si,Gyeonggi-do 17096), 주식회사 지엔티파마 (경기도용인시기흥구 용구대로 1855번길 23) filed a patent application (PCT/KR2025/000062) for "COMPOSITION AND METHOD FOR REDUCING BRAIN DAMAGE, DISABILITY, AND/OR DEATH BY COMBINED THERAPY WITH TETRAFLUOROBENZYL DERIVATIVE AND HYPOTHERMIA" on Jan 02, 2025. With publication no. WO/2025/147111, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) sys...